Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Value-Based Purchasing
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study.
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. J Thorac Oncol. 2019 10; 14(10):1704-1717.
View in:
PubMed
subject areas
Biological Specimen Banks
Biomarkers, Tumor
Clinical Trials as Topic
Diagnosis, Differential
Humans
Mesothelioma
Pleural Neoplasms
authors with profiles
Ravi Salgia